174 related articles for article (PubMed ID: 29269732)
1. Systems analysis identifies melanoma-enriched pro-oncogenic networks controlled by the RNA binding protein CELF1.
Cifdaloz M; Osterloh L; Graña O; Riveiro-Falkenbach E; Ximénez-Embún P; Muñoz J; Tejedo C; Calvo TG; Karras P; Olmeda D; Miñana B; Gómez-López G; Cañon E; Eyras E; Guo H; Kappes F; Ortiz-Romero PL; Rodríguez-Peralto JL; Megías D; Valcárcel J; Soengas MS
Nat Commun; 2017 Dec; 8(1):2249. PubMed ID: 29269732
[TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA TUG1 is downregulated in non-small cell lung cancer and can regulate CELF1 on binding to PRC2.
Lin PC; Huang HD; Chang CC; Chang YS; Yen JC; Lee CC; Chang WH; Liu TC; Chang JG
BMC Cancer; 2016 Aug; 16():583. PubMed ID: 27485439
[TBL] [Abstract][Full Text] [Related]
3. DEK oncogene is overexpressed during melanoma progression.
Riveiro-Falkenbach E; Ruano Y; García-Martín RM; Lora D; Cifdaloz M; Acquadro F; Ballestín C; Ortiz-Romero PL; Soengas MS; Rodríguez-Peralto JL
Pigment Cell Melanoma Res; 2017 Mar; 30(2):194-202. PubMed ID: 27893188
[TBL] [Abstract][Full Text] [Related]
4. High-Throughput Transcriptomics of
Siddam AD; Duot M; Coomson SY; Anand D; Aryal S; Weatherbee BAT; Audic Y; Paillard L; Lachke SA
Cells; 2023 Apr; 12(7):. PubMed ID: 37048143
[TBL] [Abstract][Full Text] [Related]
5. CELF1 preferentially binds to exon-intron boundary and regulates alternative splicing in HeLa cells.
Xia H; Chen D; Wu Q; Wu G; Zhou Y; Zhang Y; Zhang L
Biochim Biophys Acta Gene Regul Mech; 2017 Sep; 1860(9):911-921. PubMed ID: 28733224
[TBL] [Abstract][Full Text] [Related]
6. Competition between RNA-binding proteins CELF1 and HuR modulates MYC translation and intestinal epithelium renewal.
Liu L; Ouyang M; Rao JN; Zou T; Xiao L; Chung HK; Wu J; Donahue JM; Gorospe M; Wang JY
Mol Biol Cell; 2015 May; 26(10):1797-810. PubMed ID: 25808495
[TBL] [Abstract][Full Text] [Related]
7. CELF1 Mediates Connexin 43 mRNA Degradation in Dilated Cardiomyopathy.
Chang KT; Cheng CF; King PC; Liu SY; Wang GS
Circ Res; 2017 Oct; 121(10):1140-1152. PubMed ID: 28874395
[TBL] [Abstract][Full Text] [Related]
8. Melanoma proliferation and chemoresistance controlled by the DEK oncogene.
Khodadoust MS; Verhaegen M; Kappes F; Riveiro-Falkenbach E; Cigudosa JC; Kim DS; Chinnaiyan AM; Markovitz DM; Soengas MS
Cancer Res; 2009 Aug; 69(16):6405-13. PubMed ID: 19679545
[TBL] [Abstract][Full Text] [Related]
9. Antagonistic regulation of mRNA expression and splicing by CELF and MBNL proteins.
Wang ET; Ward AJ; Cherone JM; Giudice J; Wang TT; Treacy DJ; Lambert NJ; Freese P; Saxena T; Cooper TA; Burge CB
Genome Res; 2015 Jun; 25(6):858-71. PubMed ID: 25883322
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of RNA-binding protein CELF1 prevents apoptosis and destabilizes pro-apoptotic mRNAs in oral cancer cells.
Talwar S; Balasubramanian S; Sundaramurthy S; House R; Wilusz CJ; Kuppuswamy D; D'Silva N; Gillespie MB; Hill EG; Palanisamy V
RNA Biol; 2013 Feb; 10(2):277-86. PubMed ID: 23324604
[TBL] [Abstract][Full Text] [Related]
11. Identification of Targets of CUG-BP, Elav-Like Family Member 1 (CELF1) Regulation in Embryonic Heart Muscle.
Blech-Hermoni Y; Dasgupta T; Coram RJ; Ladd AN
PLoS One; 2016; 11(2):e0149061. PubMed ID: 26866591
[TBL] [Abstract][Full Text] [Related]
12. CELF1/p53 axis: a sustained antiproliferative signal leading to villus atrophy under total parenteral nutrition.
Yan JK; Zhang T; Dai LN; Gu BL; Zhu J; Yan WH; Cai W; Wang Y
FASEB J; 2019 Mar; 33(3):3378-3391. PubMed ID: 30514107
[TBL] [Abstract][Full Text] [Related]
13. Small molecule targeting CELF1 RNA-binding activity to control HSC activation and liver fibrosis.
Tan Y; Sun X; Xu Y; Tang B; Xu S; Lu D; Ye Y; Luo X; Diao X; Li F; Wang T; Chen J; Xu Q; Wu X
Nucleic Acids Res; 2022 Mar; 50(5):2440-2451. PubMed ID: 35234905
[TBL] [Abstract][Full Text] [Related]
14. Neonatal cardiac dysfunction and transcriptome changes caused by the absence of Celf1.
Giudice J; Xia Z; Li W; Cooper TA
Sci Rep; 2016 Oct; 6():35550. PubMed ID: 27759042
[TBL] [Abstract][Full Text] [Related]
15. CELF1 promotes vascular endothelial growth factor degradation resulting in impaired microvasculature in heart failure.
Chang KT; Wang LH; Lin YM; Cheng CF; Wang GS
FASEB J; 2021 May; 35(5):e21512. PubMed ID: 33811692
[TBL] [Abstract][Full Text] [Related]
16. Olive Oil-Supplemented Lipid Emulsion Induces CELF1 Expression and Promotes Apoptosis in Caco-2 Cells.
Yan JK; Zhu J; Gong ZZ; Wen J; Xiao YT; Cai W; Zhang T
Cell Physiol Biochem; 2017; 41(2):711-721. PubMed ID: 28214850
[TBL] [Abstract][Full Text] [Related]
17. CELF1 contributes to aberrant alternative splicing patterns in the type 1 diabetic heart.
Belanger K; Nutter CA; Li J; Tasnim S; Liu P; Yu P; Kuyumcu-Martinez MN
Biochem Biophys Res Commun; 2018 Sep; 503(4):3205-3211. PubMed ID: 30158053
[TBL] [Abstract][Full Text] [Related]
18. CELF1 is Up-Regulated in Glioma and Promotes Glioma Cell Proliferation by Suppression of CDKN1B.
Xia L; Sun C; Li Q; Feng F; Qiao E; Jiang L; Wu B; Ge M
Int J Biol Sci; 2015; 11(11):1314-24. PubMed ID: 26535026
[TBL] [Abstract][Full Text] [Related]
19. Critical role of DEK and its regulation in tumorigenesis and metastasis of hepatocellular carcinoma.
Yu L; Huang X; Zhang W; Zhao H; Wu G; Lv F; Shi L; Teng Y
Oncotarget; 2016 May; 7(18):26844-55. PubMed ID: 27057626
[TBL] [Abstract][Full Text] [Related]
20. CELF1 is a central node in post-transcriptional regulatory programmes underlying EMT.
Chaudhury A; Cheema S; Fachini JM; Kongchan N; Lu G; Simon LM; Wang T; Mao S; Rosen DG; Ittmann MM; Hilsenbeck SG; Shaw CA; Neilson JR
Nat Commun; 2016 Nov; 7():13362. PubMed ID: 27869122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
